Evidence map›Paper›PMID 39973929›Full record

ArticleFrontiers in microbiology2025

Biochemical characterization of the

Devon W Kavanaugh, Adeline Sivignon, Yannick Rossez, Zina Chouit, Christophe Chambon, Louane Béal, Mathilde Bonnet, Michel Hébraud, Yann Guérardel, Hang Thi Thu Nguyen and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A posttranslational modification of fimbriae drives pathogenicity inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Devon W KavanaughUniversité Clermont Auvergne, Inserm, INRAE, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
Adeline SivignonUniversité Clermont Auvergne, Inserm, INRAE, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
Yannick RossezUnité de Glycobiologie Structurale et Fonctionnelle (UGSF), Université de Lille, Lille, France.
Zina ChouitUnité de Glycobiologie Structurale et Fonctionnelle (UGSF), Université de Lille, Lille, France.
Christophe ChambonPlateforme d'Exploration du Métabolisme, Composante Protéomique (PFEMcp), Theix, France.
Louane BéalUniversité Clermont Auvergne, Inserm, INRAE, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
Mathilde BonnetUniversité Clermont Auvergne, Inserm, INRAE, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
Michel HébraudPlateforme d'Exploration du Métabolisme, Composante Protéomique (PFEMcp), Theix, France.
Yann GuérardelUnité de Glycobiologie Structurale et Fonctionnelle (UGSF), Université de Lille, Lille, France.
Hang Thi Thu Nguyen *Université Clermont Auvergne, Inserm, INRAE, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
Nicolas Barnich *Université Clermont Auvergne, Inserm, INRAE, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Escherichia coliflagellaglycobiologypathobiontpost-translational modificationstructural characterizationtype I fimbriae

Identifiers

PMID39973929
PMCPMC11839208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.